Related Experiment Videos
Selective excitotoxic pathology in the rat hippocampus
1Washington and Lee University, Lexington, Virginia.
Neuropathology and Applied Neurobiology
|October 1, 1993
Summary
Excitotoxicity in the hippocampus was studied using N-methyl-D-aspartate (NMDA) and other agents. The NMDA antagonist CPP protected against NMDA-induced damage but not quisqualate or kainate excitotoxicity.
Area of Science:
- Neuroscience
- Neurotoxicology
- Excitotoxicity
Background:
- Excitotoxicity, a process of neuronal death caused by overstimulation of excitatory neurotransmitter receptors, is implicated in various neurological disorders.
- Understanding the differential effects of various excitotoxic agents and potential neuroprotective strategies is crucial for developing therapeutic interventions.
Purpose of the Study:
- To investigate the pattern of neuronal cell loss in the hippocampus induced by different excitotoxic agents: N-methyl-D-aspartate (NMDA), ibotenate (IBO), quisqualate (QUIS), and kainate (KA).
- To evaluate the neuroprotective efficacy of 3-(+/-)-2-carboxypiperazin-4-yl-propyl-1-phosphonate (CPP), an NMDA receptor antagonist, against these excitotoxic insults.
Main Methods:
- Multiple microinjections of NMDA, IBO, QUIS, and KA were administered into the hippocampus of experimental subjects.
- Histological evaluation was performed after a 7-day survival period to assess neuronal damage.
- The protective effects of CPP were assessed following co-administration with the excitotoxic agents.
Main Results:
- NMDA and IBO caused extensive hippocampal cell loss, sparing extrahippocampal structures.
- QUIS and KA induced limited hippocampal damage but significant extrahippocampal neurodegeneration, including in the entorhinal cortex and amygdala.
- CPP provided significant protection against NMDA and IBO neurotoxicity within the hippocampus.
- CPP offered partial protection to CA1 cells and significant protection to extrahippocampal sites against QUIS and KA, suggesting indirect NMDA receptor involvement.
Conclusions:
- Different excitotoxic agents exhibit distinct patterns of neuronal damage, with NMDA/IBO primarily affecting the hippocampus and QUIS/KA causing both hippocampal and extrahippocampal damage.
- The NMDA receptor antagonist CPP is effective in preventing NMDA-induced excitotoxicity but shows limited efficacy against QUIS/KA-induced hippocampal damage.
- Extrahippocampal damage induced by QUIS and KA appears to be mediated indirectly through NMDA receptor activation, highlighting a potential therapeutic target.